Monthly Archives: September 2018
Misoprostol for aspirin-induced small bowel enteropathy: a small step in the right direction
ROCKin’ intestinal cell fate, a potential avenue to improve glucose sensitivity
Cytokinesis and the Hippo Pathway: New Molecular Links Between Intimate Partners
Cytokinesis is the elegant final event of the cell cycle that separates 2 daughter cells. Because aberrant cytokinesis is seen in both normal and pathologic processes, it has been unclear if inhibiting cytokinesis would be therapeutically effective in … Continue reading
Personalized Treatment in Inflammatory Bowel Disease: For Another Time
For decades plagued by therapies of limited efficacy, the recent arrival of an embarrassment of riches in effective therapeutics for inflammatory bowel disease (IBD)1,2—likely to grow further in coming years3-6—has made personalization of therapy e… Continue reading
Methotrexate Monotherapy for Induction and Maintenance of Clinical Remission in Ulcerative Colitis: Dead on Arrival
Healthy Lifestyle Factors Associated With Lower Risk of Colorectal Cancer Irrespective of Genetic Risk
The combined effects of healthy lifestyle factors on colorectal cancer (CRC) risk are unclear. We aimed to develop a healthy lifestyle score, to investigate the joint effects of modifiable lifestyle factors on reduction of CRC risk and determine whethe… Continue reading